References
- Mitanchez D, Yzydorczyk C, Siddeek B, et al. The offspring of the diabetic mother-short- and long-term implications. Best Pract Res Clin Obstet Gynaecol 2015;29:256–69.
- Xu H, Simonet F, Luo ZC. Optimal birth weight percentile cut-offs in defining small- or large-for-gestational-age. Acta Paediatr 2010;99:550–5.
- Chu C, Gui YH, Ren YY, Shi LY. The impacts of maternal gestational diabetes mellitus (GDM) on fetal hearts. Biomed Environ Sci 2012;25:15–22.
- Hay WW. Jr. Care of the infant of the diabetic mother. Curr Diab Rep 2012;12:4–15.
- Haddouche M, Aribi M, Moulessehoul S, et al. Alteration of antioxidant defense status precedes humoral immune response abnormalities in macrosomia. Med Sci Monit 2011;17:CR650–6.
- Hender C, Karakas M, Koenig W. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin Pharmacol Ther 2011;90:52–66.
- López-Yoldi M, Moreno-Aliaga MJ, Bustos M. Cardiotrophin-1: a multifaceted cytokine. Cytokine Growth Factor Rev 2015;26:523–32.
- Asrih M, Mach F, Quercioli A, et al. Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity. Mediators Inflamm 2013;2013:370715.
- Gamella-Pozuelo L, Fuentes-Calvo I, Gomes-Marcos MA, et al. Plasma Cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk. Medicine (Baltimore) 2015;94:e1218.
- Hinson JT, Chopra A, Nafissi N, et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 2015;349:982–6.
- Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 2008;77:637–48.
- Lahmers S, Wu Y, Call DR, et al. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res 2004;94:505–13.
- Wu Y, Cazorla O, Labeit D, et al. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J Mol Cell Cardiol 2000;32:2151–62.
- Garlanda C, Bottazzi B, Bastone a, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005;23:337–66.
- Todoric J, Handisurya A, Knapp B, et al. Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes. Eur J Clin Invest 2013;43:341–9.
- Lannergård A, Rosenström F, Normann E, Larsson A. Serum pentraxin 3 concentrations in neonates. Ups J Med Sci 2014;119:62–4.
- Krzystolik A, Dziedziejko V, Safranow K, et al. Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients? Scand J Clin Lab Invest 2015;75:398–406.
- Koonen DP, Jensen MK, Handberg A. Soluble CD36- a marker of the (pathophysiological) role of CD36 in the metabolic syndrome? Arch Physiol Biochem 2011;117:57–63.
- Latchman DS. Cardiotrophin-1: a novel cytokine and its effects in the heart and other tissues. Pharmacol Ther 2000;85:29–37.
- Diao YQ, Jiang L, Zhang HF, et al. Changes of plasma cardiotrophin-1 levels in neonates with myocardial ischemic injury. Zhongguo Dang Dai Er Ke Za Zhi 2015;17:118–21.
- Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol 2009;21:521–6.
- Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995;6:168–74.
- Eidelman AI, Samueloff A. The pathophysiology of the fetus of the diabetic mother. Semin Perinatol 2002; 26:232–6.
- Loukovaara M, Leinonen P, Teramo K, et al. Fetal hypoxia is associated with elevated cord serum C-reactive protein levels in diabetic pregnancies. Biol Neonate 2004;85:237–42.
- Houben ML, Nikkels PG, van Bleek GM, et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009;4:e6572.
- Gerull B. The rapidly evolving role of titin in cardiac physiology and cardiomyopathy. Can J Cardiol 2015;31:1351–9.
- LeWinter MM, Granzier HL. Cardiac titin and heart disease. J Cardiovasc Pharmacol 2014;63:207–12.
- Violi F, Pastori D. Pentraxin 3 - a link between obesity, inflammation and vascular disease? Circ J 2016;80:327–8.
- Yildirim M, Simavli SA, Uysal Derbent A, et al. Is there any relationship between plasma pentraxin 3 levels and gestational diabetes mellitus? Gynecol Obstet Invest 2015;80:223–7.
- Larson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation 2011;34:448–51.